U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Obesity Management Interventions Delivered in Primary Care for Patients with Osteoarthritis: A Review of the Clinical Effectiveness

Obesity Management Interventions Delivered in Primary Care for Patients with Osteoarthritis: A Review of the Clinical Effectiveness

Rapid Response Report: Summary with Critical Appraisal

Osteoarthritis (OA) is the most common joint disorder, affecting more than 10% of Canadian adults with symptoms in the hands, knees, hips, back, and neck. In Canada, joint damage from osteoarthritis accounts for over 80% of hip and over 90% of knee replacements. Obesity is recognized as the strongest modifiable risk factor in osteoarthritis. It has been reported that obese women and men have nearly four times and greater than five times, respectively, the risk of knee arthritis compared to their non-obese counterparts. The association between being overweight or obese and increased stress on weight-bearing joints like the knees and hips seem intuitive, but the exact manner in which excess weight influences OA is unclear. However, being overweight has been associated with higher rates of hand OA in some studies. Thus, osteoarthritis is considered an active disease process with joint destruction driven by both biomechanical and pro-inflammatory factors.

While effective weight management is a laudable health goal for all, it is especially important for obese patients with knee OA because being only 10 pounds overweight increases the force on the knee by 30 to 60 pounds with each step which exacerbates the OA and elevates the risk for future total knee replacement. In addition to alleviating sheer pain, stiffness and risk of mobility disability, weight loss reduces the risk of vascular events which is reported to be higher in people with OA compared to people without OA.

Substantial improvements in physical function in obese patients with OA have been reported with even modest weight loss (≥ 5% of baseline weight). Some researchers have concluded that in elderly persons (mean age 70.5 years), if obese men lost enough weight to fall into the overweight category and men in the overweight category lost enough weight to move into the normal weight category, the risk of developing knee OA would decrease by 21.5%. Similar changes in weight category by women would result in a 33% decrease.

Even so, weight loss could potentially result in undesirable reductions in lean muscle and bone mass with the potential to aggravate age-related risk of disability and osteoporotic fractures which compromise quality of life and life expectancy. The objective of this report is to review the evidence for clinical effectiveness of long-term primary care weight management interventions to halt or minimize the progression of osteoarthritis in obese patients.

Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should be considered along with other types of information and health care considerations. The information included in this response is not intended to replace professional medical advice, nor should it be construed as a recommendation for or against the use of a particular health technology. Readers are also cautioned that a lack of good quality evidence does not necessarily mean a lack of effectiveness particularly in the case of new and emerging health technologies, for which little information can be found, but which may in future prove to be effective. While CADTH has taken care in the preparation of the report to ensure that its contents are accurate, complete and up to date, CADTH does not make any guarantee to that effect. CADTH is not liable for any loss or damages resulting from use of the information in the report.

Copyright © 2014 Canadian Agency for Drugs and Technologies in Health.

Copyright: This report contains CADTH copyright material and may contain material in which a third party owns copyright. This report may be used for the purposes of research or private study only. It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner.

Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK258685PMID: 25473700

Views

Other titles in this collection

Related information

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...